Skip to main content
FDA clears Masimo's O3 regional oximetry device for pediatric use
6/1/2017

Masimo has obtained clearance from the FDA to market its O3 regional oximetry monitoring system with an O3 pediatric sensor, allowing it to be used in pediatric patients weighing less than 88 pounds and more than 11 pounds. The system, which has already been cleared for use in adults, enables continuous monitoring of cerebral oxygen saturation using near-infrared spectroscopy.

Full Story: